Furthermore, the NSUN2-mediated GLUT1 stabilization via m5C modification enhances the competitive advantage of tumor cells in glucose acquisition, accelerating malignancy in HCC [41]. The gene discussed is SLC2A1; the disease is hepatocellular carcinoma.